- Home
- KNSA vs RSI Comparison
KNSA vs RSI Comparison
Compare KNSA & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- RSI
- Stock Information
- Founded
- KNSA 2015
- RSI 2012
- Country
- KNSA United Kingdom
- RSI United States
- Employees
- KNSA N/A
- RSI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- RSI Services-Misc. Amusement & Recreation
- Sector
- KNSA Health Care
- RSI Consumer Discretionary
- Exchange
- KNSA Nasdaq
- RSI Nasdaq
- Market Cap
- KNSA 1.4B
- RSI 1.2B
- IPO Year
- KNSA 2018
- RSI N/A
- Fundamental
- Price
- KNSA $20.02
- RSI $13.68
- Analyst Decision
- KNSA Strong Buy
- RSI Buy
- Analyst Count
- KNSA 5
- RSI 9
- Target Price
- KNSA $36.60
- RSI $13.14
- AVG Volume (30 Days)
- KNSA 567.6K
- RSI 2.2M
- Earning Date
- KNSA 02-25-2025
- RSI 02-26-2025
- Dividend Yield
- KNSA N/A
- RSI N/A
- EPS Growth
- KNSA N/A
- RSI N/A
- EPS
- KNSA N/A
- RSI N/A
- Revenue
- KNSA $384,098,000.00
- RSI $863,767,000.00
- Revenue This Year
- KNSA $60.10
- RSI $33.49
- Revenue Next Year
- KNSA $34.22
- RSI $13.37
- P/E Ratio
- KNSA N/A
- RSI N/A
- Revenue Growth
- KNSA 54.41
- RSI 30.31
- 52 Week Low
- KNSA $16.56
- RSI $5.22
- 52 Week High
- KNSA $28.15
- RSI $16.78
- Technical
- Relative Strength Index (RSI)
- KNSA 53.15
- RSI 40.90
- Support Level
- KNSA $19.31
- RSI $15.18
- Resistance Level
- KNSA $20.20
- RSI $16.78
- Average True Range (ATR)
- KNSA 0.80
- RSI 0.89
- MACD
- KNSA 0.06
- RSI -0.06
- Stochastic Oscillator
- KNSA 72.80
- RSI 3.73
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses primarily on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.